CBT versus unspecific control conditions | |||||||
Analysis | Name | Control | MD | 95% CI | % change | ||
Analysis 1.1 ADHD symptoms (observer) |
1.1.1 | Solanto 2010 | 73.19 | −6.25 | −11.04 | −1.46 | −9% (95% CI −15 to −2) |
1.1.2a | Hepark 2015 | 28.00 | −6.5 | −9.77 | −3.23 | −23% (95% CI −35 to −12) | |
1.1.2b | Stevenson 2002 | 112.9 | −39.2 | −52.76 | −25.64 | −35% (95% CI −47 to −23) | |
Analysis 1.2 ADHD symptoms (self‐reported) |
1.2.1a | Hirvikoski 2011 | 27.28 | −2.81 | −8.02 | 2.4 | −10% (95% CI −29 to 9) |
1.2.1b | Solanto 2010 | 76.8 | −1.00 | −6.15 | 4.15 | −1% (95% CI −8 to 5) | |
1.2.2a | Gu 2017 | 71.77 | −11.06 | −15.75 | −6.37 | −15% (95% CI −22 to −9) | |
1.2.2b | Hepark 2015 | 28.8 | −5.8 | −8.86 | −2.74 | −20% (95% CI −31 to −10) | |
1.2.2c | Pettersson 2017 | 29.72 | −2.38 | −8.11 | 3.35 | −8% (95% CI −27 to 11) | |
1.2.2d | Schoenberg 2014 | 31.3 | −8.3 | −12.53 | −4.07 | −27% (95% CI −40 to −13) | |
1.2.2e | Virta 2010 | −4.6 | −8.7 | −17.47 | 0.07 | 189% (95% CI −2 to 380) | |
Analysis 1.3 Inattention (clinician) |
1.3.1 | Solanto 2010 | 16.18 | −2.47 | −4.43 | −0.51 | −15% (95% CI −27 to −3) |
1.3.2 | Hepark 2015 | 16.5 | −4.1 | −6.00 | −2.2 | −25% (95% CI −36 to −13) | |
Analysis 1.4 Inattention (self‐reported) |
1.4.1a | Gu 2017 | 64.23 | −12.59 | −17.53 | −7.65 | −20% (95% CI −27 to −12) |
1.4.1b | Hepark 2015 | 16.1 | −3.3 | −5.02 | −1.58 | −20% (95% CI −31 to −10) | |
1.4.2c | Moëll 2015 | 27.93 | −5.01 | −7.16 | −2.86 | −18% (95% CI −26 to −10) | |
1.4.2d | Schoenberg 2014 | 17.4 | −5.2 | −7.47 | −2.93 | −30% (95% CI −43 to −17) | |
Analysis 1.5 Hyperactivity‐impulsivity (clinician) |
1.5.1 | Hepark 2015 | 11.5 | −2.5 | −4.63 | −0.37 | −22% (95% CI −40 to −3) |
Analysis 1.6 Hyperactivity‐impulsivity (self‐reported) |
1.6.1a | Gu 2017 | 71.15 | −10.29 | −14.91 | −5.67 | −14% (95% CI −21 to −8) |
1.6.1b | Hepark 2015 | 12.6 | −2.3 | −4.28 | 0.32 | −18% (95% CI −34 to 3) | |
1.6.1c | Moëll 2015 | 20.85 | −1.31 | −4.81 | 2.19 | −6% (95% CI −23 to 11) | |
1.6.1d | Schoenberg 2014 | 14.00 | −3.2 | −6.05 | −0.35 | −23% (95% CI −43 to −3) | |
Analysis 1.7 Depression (self‐reported) |
1.7.1 | Solanto 2010 | 9.08 | 0.58 | −2.8 | 3.96 | 6% (95% CI −31 to 44) |
1.7.2a | Gu 2017 | 9.42 | −2.35 | −4.01 | −0.69 | −25% (95% CI −43 to −7) | |
1.7.2b | Hepark 2015 | 11.8 | −2.7 | −6.51 | 1.11 | −23% (95% CI −55 to 9) | |
1.7.2c | Moëll 2015 | 7.7 | −1.08 | −3.48 | 1.32 | −14% (95% CI −45 to 17) | |
1.7.2d | Pettersson 2017 | 15.11 | −1.92 | −8.63 | 4.79 | −13% (95% CI −57 to 32) | |
1.7.2e | Virta 2010 | −1.5 | −3.1 | −10.22 | 4.02 | 207% (95% CI −268 to 681) | |
Analysis 1.8 Anxiety (clinician) | 1.8.1 | Solanto 2010 | 8.88 | −0.81 | −3.21 | 1.59 | −9% (95% CI −36 to 18) |
Analysis 1.9 Anxiety (self‐reported) |
1.9.1a | Gu 2017 | 15.08 | −5.58 | −8.97 | −2.19 | −37% (95% CI −59 to −15) |
1.9.1b | Hepark 2015 | 90.8 | −12.3 | −22.56 | −2.04 | −14% (95% CI −25 to −2) | |
1.9.1c | Moëll 2015 | 8.81 | −0.85 | −2.67 | 0.97 | −10% (95% CI −30 to 11) | |
1.9.1d | Pettersson 2017 | 15.22 | −1.55 | −8.04 | 4.94 | −10% (95% CI −53 to 32) | |
Analysis 1.10 State anger (self‐reported) | 1.10.1 | Stevenson 2002 | 14.00 | −3.3 | −5.62 | −0.98 | −24% (95% CI −40 to −7) |
Analysis 1.11 Trait anger (self‐reported) | 1.11.1 | Stevenson 2002 | 24.3 | −3.8 | −7.63 | 0.03 | −16% (95% CI −31 to 0) |
Analysis 1.12 Self‐steem (self‐reported) |
1.12.1 | Solanto 2010 | −1.3 | 0.00 | −1.85 | 1.85 | 0% (95% CI −142 to 142) |
1.12.2 | Stevenson 2002 | 97.4 | 12.4 | 4.55 | 20.25 | 13% (95% CI 5 to 21) | |
Analysis 1.13 Qualfeity of life (self‐reported) |
1.13.1a | Pettersson 2017 | 41.91 | 4.99 | −6.23 | 16.21 | 12% (95% CI −15 to 39) |
1.13.1b | Virta 2010 | 59.2 | 1.7 | −14.7 | 18.1 | 3% (95% CI −25 to 31) | |
CBT plus pharmacotherapy versus pharmacotherapy alone | |||||||
Analysis | Name | Control | MD | 95% CI | % change | ||
Analysis 2.1 ADHD symptoms (clinician) |
2.1a | Emilsson 2011 | 35.94 | −6.06 | −10.01 | −2.11 | −17% (95% CI −28 to −6) |
2.1b | Safren 2005 | 20.8 | −5.61 | −12.11 | 0.89 | −27% (95% CI −58 to 4) | |
Analysis 2.2 ADHD symptoms (self‐reported) |
2.2a | Emilsson 2011 | 23.47 | −6.25 | −11.72 | −0.78 | −27% (95% CI −50 to −3) |
2.2b | Safren 2005 | 23.87 | −9.12 | −15.69 | −2.55 | −38% (95% CI −66 to −11) | |
Analysis 2.3 Inattention (self‐reported) | 2.3 | Emilsson 2011 | 14.71 | −4.54 | −7.75 | −1.33 | −31% (95% CI −53 to −9) |
Analysis 2.4 Hyperactivity‐impulsivity (self‐reported) |
2.4 | Emilsson 2011 | 8.76 | −1.7 | −5.29 | 1.89 | −19% (95% CI −60 to 22) |
Analysis 2.5 Clinical Global Impression (clinician) |
2.5a | Emilsson 2011 | 3.88 | −0.7 | −1.31 | −0.09 | −18% (95% CI −34 to −2) |
2.5b | Safren 2005 | 4.13 | −0.82 | −1.51 | −0.13 | −20% (95% CI −37 to −3) | |
Analysis 2.6 Depression (clinician) | 2.6 | Safren 2005 | 10.00 | −5.56 | −9.71 | −1.41 | −56% (95% CI −97 to −14) |
Analysis 2.7 Depression (self‐reported) |
2.7a | Emilsson 2011 | 15.41 | −8.19 | −13.76 | −2.62 | −53% (95% CI −89 to −17) |
2.7b | Safren 2005 | 12.4 | −4.77 | −9.19 | −0.35 | −38% (95% CI −74 to −3) | |
Analysis 2.8 Anxiety (clinician) | 2.8 | Safren 2005 | 12.93 | −5.68 | −10.32 | −1.04 | −44% (95% CI −80 to −8) |
Analysis 2.9 Anxiety (self‐reported) | 2.9a | Emilsson 2011 | 15.29 | −4.29 | −11.36 | 2.78 | −28% (95% CI −74 to 18) |
2.9b | Safren 2005 | 7.2 | −3.51 | −6.53 | −0.49 | −49% (95% CI −91 to −7) | |
CBT versus other specific interventions | |||||||
Analysis | Name | Control | MD | 95% CI | % change | ||
Analysis 3.1 ADHD symptoms (clinician) |
3.1.1 | Safren 2010 | 19.19 | −4.73 | −8.79 | −0.67 | −25 (95% CI −46 to −3) |
3.1.2 | Virta 2010 | −4.50 | −0.8 | −1.6 | 0 | 18% (95% CI 0 to 36) | |
Analysis 3.2 ADHD symptoms (self‐reported) |
3.2.1 | Safren 2010 | 19.12 | −7.28 | −11.68 | −2.88 | −38% (95% CI −61 to −15) |
3.2.2 | Virta 2010 | −10.55 | −2.75 | −14.93 | 9.43 | 26% (95% CI −89 to 142) | |
3.2.3 | Vidal Estrada 2013 | 24.29 | 1.31 | −5.92 | 8.54 | 5% (95% CI −24 to 35) | |
3.2.4 | Fleming 2015 | 75.56 | −15.27 | −29.52 | −1.02 | −20% (95% CI −39 to −1) | |
Analysis 3.3 Inattention (self‐reported) |
3.3.1 | Vidal Estrada 2013 | 18.58 | 1.35 | −4.62 | 7.32 | 7% (95% CI −25 to 39) |
3.3.2 | Fleming 2015 | 20.94 | −2 | −5.42 | 1.42 | −10% (95% CI −26 to 7) | |
Analysis 3.4 Hyperactivity | 3.4.1 | Vidal Estrada 2013 | 13.88 | 1.72 | −4.41 | 7.85 | 12% (95% CI −32 to 57) |
Analysis 3.5 Impulsivity | 3.5.1 | Vidal Estrada 2013 | 14.76 | 2.84 | −3.26 | 8.94 | 19% (95% CI −22 to 61) |
Analysis 3.6 Clinical Global Impression (clinician) |
3.6.1 | Safren 2010 | 3.73 | −0.53 | −1.09 | 0.03 | −14% (95% CI −29 to −1) |
3.6.2 | Vidal Estrada 2013 | 4.15 | 0.18 | −0.19 | 0.55 | 4% (95% CI −5 to 13) | |
Analysis 3.7 Clinical Global Impression (self‐reported) |
3.7.1 | Vidal Estrada 2013 | 4.17 | 0.29 | −0.32 | 0.9 | 7% (95% CI −8 to 22) |
Analysis 3.8 Depression (self‐reported) |
3.8.1 | Virta 2010 | −1.67 | −2.93 | −8.88 | 3.02 | 175% (95% CI −181 to 532) |
3.8.2 | Vidal Estrada 2013 | 13.64 | −1.24 | −9.37 | 6.89 | −9% (95% CI −69 to 51) | |
3.8.3 | Fleming 2015 | 13.56 | −2.91 | −8.42 | 2.6 | −21 (95% CI −62 to 19) | |
Analysis 3.9 Anxiety (self‐reported) |
3.9.1 | Vidal Estrada 2013 | 29.42 | −4.22 | −12.48 | 4.04 | −14% (95% CI −42 to 14) |
3.9.2 | Fleming 2015 | 15.75 | −5.93 | −12.91 | 1.05 | −38% (95% CI −82 to 7) | |
Analysis 3.10 Qualfeity of life (self‐reported) |
3.10.1 | Virta 2010 | 65.20 | −4.3 | −17.31 | 8.71 | −7% (95% CI −27 to 13) |
3.10.2 | Vidal Estrada 2013 | 207.35 | 33.14 | −35.76 | 102.04 | 16% (95% CI −17 to 49) | |
3.10.3 | Fleming 2015 | 52.8 | 14.29 | 6.13 | 22.45 | 27% (95% CI 12 to 43) |